| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/1990 | US4895715 Nonsteroidal antiandrogen, antiestrogen or 4-hydroxyandrostenedione |
| 01/23/1990 | US4895676 Bendazac or 5-hydroxy derivative |
| 01/23/1990 | EP0294462A4 Protection against aminoglycoside-induced nephrotoxicity. |
| 01/23/1990 | CA1264762A1 2-pyrrolidone derivative |
| 01/23/1990 | CA1264758A1 Rhodanine derivatives and process for preparing the same |
| 01/23/1990 | CA1264753A1 2-pyridylcarboxamides |
| 01/23/1990 | CA1264751A1 Base addition salts of omeprazole |
| 01/23/1990 | CA1264749A1 Tricyclic amines |
| 01/23/1990 | CA1264748A1 .beta.-carboline-3-oxadiazolyl derivatives, method of preparing the same and_their use |
| 01/23/1990 | CA1264747A1 Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase |
| 01/23/1990 | CA1264746A1 Thiobarbituric acid derivatives |
| 01/23/1990 | CA1264742A1 Pyrazolo(4,3-d)pyrimidine derivative, process for its production, and antihyperlipidemic or antiatherosclerotic agent containing it |
| 01/23/1990 | CA1264741A1 Tetrahydronaphthalene derivatives as dopamine agonists |
| 01/23/1990 | CA1264740A1 Tetrapyrrole therapeutic agents |
| 01/23/1990 | CA1264738A1 Treatment of tumors in mammals |
| 01/23/1990 | CA1264691A1 Antibiotic crisamicin a and compositions thereof |
| 01/23/1990 | CA1264670A1 Treatment of skin disorders |
| 01/18/1990 | DE3827472A1 Verfahren zum herstellen einer waessrigen loesung von lysin-(alpha)-methyl-4-(2'-thienylcarbonyl)phenylacetat fuer die oertliche anwendung in der augenheilkunde A method of preparing an aqueous solution of lysine (alpha) methyl-4- (2'-thienylcarbonyl) phenylacetate for topical application in ophthalmology |
| 01/17/1990 | EP0351385A2 New amidino and guanidino derivatives |
| 01/17/1990 | EP0351353A1 Anti-inflammatory pharmaceutical composition with an ibuprofen base, with elimination, in solution, of the bitter taste, burning in the throat and intestinal toxicity |
| 01/17/1990 | EP0351352A2 2-Substituted ergolines, their preparation and use |
| 01/17/1990 | EP0351351A2 2'-,12'- or 13'-Substituted 3-(8'-alpha-ergolinyl)-1,1-diethyl urea, their preparation and use in medicines |
| 01/17/1990 | EP0351348A2 Thiazole derivatives and process for the preparation thereof |
| 01/17/1990 | EP0351301A2 Pharmaceutical composition for the prevention of sexually transmissible diseases |
| 01/17/1990 | EP0351283A1 2-[(4-Piperidinyl)methyl]-2,3-dihydro-1H-isoindole and 2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and therapeutical use |
| 01/17/1990 | EP0351282A1 (1-Hydroxy-2-piperidinyl alkyl)-2-indolone, 2-quinolinones, 2-benzo[b]azepinone, 2-benzimidazolone and 2-quinazolinone derivatives, their preparation and therapeutical use |
| 01/17/1990 | EP0351255A2 Derivatives of 2-[(4-piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy |
| 01/17/1990 | EP0351215A2 Ester of 9-(2-hydroxyethoxymethyl) guanine |
| 01/17/1990 | EP0351214A1 Anti-inflammatory aryl derivatives |
| 01/17/1990 | EP0351213A2 2-Indolones substituted in 5 by a cyclic hydrazide radical, their preparation and their use in cardio-active medicaments |
| 01/17/1990 | EP0351194A2 Thiazole derivatives having a 5-lipoxygenase-inhibiting activity |
| 01/17/1990 | EP0351173A2 Substance having anti-retrovirus activity |
| 01/17/1990 | EP0351126A2 Process for the production of 02,2'-anhydro-1-(beta-D-arabinofuranosyl)thymine |
| 01/17/1990 | EP0351058A1 Pyrimidopyrimidine derivatives |
| 01/17/1990 | EP0351017A2 Pharmaceutical composition useful for the treatment of cardiovascular diseases |
| 01/17/1990 | EP0350990A1 Pyridazinone derivatives |
| 01/17/1990 | EP0350973A1 Means and product for the diagnosis and therapy of tumours and for the treatment of weaknesses of the cellular and humoral immune system |
| 01/17/1990 | EP0350913A1 Ibudilast lipid microsphere and method of preparation thereof |
| 01/17/1990 | EP0350878A2 Conjugated gamma-oxybutenolide compounds for treating ulcer |
| 01/17/1990 | EP0350864A1 Aqueous solution containing fat-soluble vitamin K |
| 01/17/1990 | EP0350846A2 Condensed heterocyclic compounds and their use in therapy |
| 01/17/1990 | EP0350840A2 Antiviral agent |
| 01/17/1990 | EP0350805A1 Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
| 01/17/1990 | EP0350801A2 Polyprenols and polyprenyl phosphates for the inhibition of tumour metastasis |
| 01/17/1990 | EP0350742A1 6-Merkaptopurines derivatives, their preparation and their use against retrovirus infections |
| 01/17/1990 | EP0350738A2 (S)-emopamil for use in the treatment of migraine |
| 01/17/1990 | EP0350733A2 7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridone-carboxylic-acid derivatives, method for their preparation and for substituted mono- and bi-cyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions |
| 01/17/1990 | EP0350707A1 Androstane derivatives |
| 01/17/1990 | EP0350701A2 Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes |
| 01/17/1990 | EP0350650A1 Therapeutic composition for hepatic encephalopathy |
| 01/17/1990 | EP0350623A2 BU-3420T antitumor antibiotic |
| 01/17/1990 | EP0350506A1 Pulmonary surfactant protein and related polypeptide |
| 01/17/1990 | EP0248824B1 Use of cis-n-(2 aminocycloaliphatic) benzene acetamide and benzamide for the manufacture of anticonvulsants |
| 01/17/1990 | EP0232277B1 Pharmaceutical preparations in the form of instant granules or tablets, and process for their manufacture |
| 01/17/1990 | EP0190367B1 Benzo adh bdcinnoline compounds, process for their preparation, and mecidinal composition containing them |
| 01/17/1990 | CN1038838A 聚醚抗菌素 Polyether antibiotic |
| 01/17/1990 | CN1038818A Production of the oral medicine, polysaccharide of the root of bidentate achyranthes |
| 01/17/1990 | CN1038814A Cephem compounds and processes for preparation thereof |
| 01/17/1990 | CN1038813A Process for preparing tetrahydrofolic acid |
| 01/17/1990 | CN1038807A Indole derivatives |
| 01/17/1990 | CN1038765A Stabilized f g f composition and production thereof |
| 01/17/1990 | CN1038759A Improved antiinelammatory compositions and methods |
| 01/17/1990 | CN1038758A Pharmaceutical composition and process for preparing it |
| 01/17/1990 | CN1038751A Preparation of riboflavin, produced by microbial method, in form of spray-dried granules or microgranules |
| 01/17/1990 | CN1006464B Process for preparing naphthalene derivatives |
| 01/16/1990 | US4894476 Gabapentin monohydrate and a process for producing the same |
| 01/16/1990 | US4894459 Histamine h2 antagonist |
| 01/16/1990 | US4894458 Quinolonecarboxylic acid derivatives and their preparation |
| 01/16/1990 | US4894455 Food supplements for zinc deficiency |
| 01/16/1990 | US4894454 Pharmaceutical preparations |
| 01/16/1990 | US4894449 Gastrointestinal disorders |
| 01/16/1990 | US4894393 Dithiocarbamate-choline adduts and use thereof in treatment of brain diseases |
| 01/16/1990 | US4894392 Bactericides, fungicides, infections |
| 01/16/1990 | US4894391 Hypotensive agents, nervous system disorders, antidiarrheoral agents |
| 01/16/1990 | US4894390 Vision defects |
| 01/16/1990 | US4894389 Novel aminoalkyl-substituted heterocyclic sulfur compounds |
| 01/16/1990 | US4894388 Glycosidase inhibitors and use thereof |
| 01/16/1990 | US4894387 5-Substituted-3-aminoalkyl indole derivatives |
| 01/16/1990 | US4894385 Anticoagulants |
| 01/16/1990 | US4894382 Fungicides |
| 01/16/1990 | US4894378 Lowering blood sugar with novel 4-thienyl-dihydropyridines |
| 01/16/1990 | US4894377 β-carbolines and their use as medicinal agents |
| 01/16/1990 | US4894376 Methods of treating diseases characterized by hyperexcitability of neurons |
| 01/16/1990 | US4894375 Method of controlling mycotic infections and compositions therefor |
| 01/16/1990 | US4894374 Antiinflammatory agents, enzyme tissue destruction, interleukin inhibitors |
| 01/16/1990 | US4894373 Antiestrogens and their use in treatment of menopause and osteoporosis |
| 01/16/1990 | US4894371 3-substituted-aminomethyl cephalosporin derivatives |
| 01/16/1990 | US4894369 Novel 2β-morpholino-androstane derivatives |
| 01/16/1990 | US4894366 Autoimmune disease, infections, microbiocides |
| 01/16/1990 | US4894365 Combinations of FU and BVU as anti-adenocarcinoma agents |
| 01/16/1990 | US4894363 Derivatives of serotonin |
| 01/16/1990 | US4894240 Cores, membranes, multilayer, time-release agents |
| 01/16/1990 | US4894238 Controlled release compositions |
| 01/16/1990 | US4894237 Antiinflammatory pharmaceutical composition endowed with sustained effect for topical use |
| 01/16/1990 | US4894236 Direct compression tablet binders for acetaminophen |
| 01/16/1990 | US4894235 Nifedipine-containing form of administration and method for its production |
| 01/16/1990 | CA1264471A1 N-[[5-(trifluoromethyl)-6-methoxy-1- naphthalenyl]-thioxomethyl and carbonyl]-n- methylglycinamides |
| 01/16/1990 | CA1264470A1 Stable salts of sam with polyanions |
| 01/16/1990 | CA1264442A1 Electrolyte solutions and in vivo use thereof |
| 01/16/1990 | CA1264441A1 Galenical retard form |